Updates and Insights from Our CEO

Webinar: What’s the Role of Inflammation in Alzheimer’s disease?

What’s New In Alzheimer’s Research?

FDA APPROVES KISUNLA™ (DONANEMAB) FOR TREATMENT OF ALZHEIMER’S DISEASE

ADVISORY COMMITTEE (ADCOMM) RESULTS: DONANEMAB

CURE ALZHEIMER’S FUND PRESENTS THE JEFFREY L. MORBY PRIZE FOR EXCEPTIONAL RESEARCH